You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY20 is not expected to be complete until September, 2021.

  1. Biphase Extended Release Tablet Formulation for Nerve Agent Pretreatment

    SBC: Zymeron Corporation            Topic: CBD181004

    Nerve agents exert their toxic effect by binding to and inactivating enzyme acetylcholinesterase, a key enzymatic regulator of cholinergic neurotransmission. The binding becomes irreversible after a varying amount of time with nerve agents and this aging process limits the treatment window of oxime reactivators. To enhance the current antidote treatment of nerve agent autoinjectors, a pyridostigmi ...

    SBIR Phase I 2019 Department of DefenseOffice for Chemical and Biological Defense
  2. Low-Output High Precision Automated Powder Disseminator

    SBC: ADVANCED MECHANICAL SYSTEMS TECHNOLOGY,            Topic: CBD06101

    This proposal presents a Phase I SBIR project to develop a high precision, low disperse rate powder disseminator for the US Army. In the development of the sensitive detecting agent, we need to release a precise amount of C&B agents in the controlled detection experiments. However, such a technology does not exist at the present time. After examining existing technologies, we believe that the r ...

    SBIR Phase I 2006 Department of DefenseOffice for Chemical and Biological Defense
US Flag An Official Website of the United States Government